India · Delayed Price · Currency is INR KMS Medisurgi Statistics
Total Valuation
KMS Medisurgi has a market cap or net worth of INR 438.24 million. The enterprise value is 441.92 million.
| Market Cap | 438.24M |
| Enterprise Value | 441.92M |
Important Dates
The last earnings date was Saturday, May 30, 2026.
| Earnings Date | May 30, 2026 |
| Ex-Dividend Date | Sep 23, 2025 |
Share Statistics
KMS Medisurgi has 3.30 million shares outstanding. The number of shares has increased by 0.53% in one year.
| Current Share Class | 3.30M |
| Shares Outstanding | 3.30M |
| Shares Change (YoY) | +0.53% |
| Shares Change (QoQ) | -0.16% |
| Owned by Insiders (%) | 68.19% |
| Owned by Institutions (%) | 3.52% |
| Float | 415,790 |
Valuation Ratios
The trailing PE ratio is 179.46.
| PE Ratio | 179.46 |
| Forward PE | n/a |
| PS Ratio | 3.59 |
| PB Ratio | 5.27 |
| P/TBV Ratio | 5.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 28.96 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 48.67, with an EV/FCF ratio of -213.90.
| EV / Earnings | 180.01 |
| EV / Sales | 3.62 |
| EV / EBITDA | 48.67 |
| EV / EBIT | 101.19 |
| EV / FCF | -213.90 |
Financial Position
The company has a current ratio of 5.02, with a Debt / Equity ratio of 0.09.
| Current Ratio | 5.02 |
| Quick Ratio | 2.96 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.85 |
| Debt / FCF | -3.74 |
| Interest Coverage | 4.10 |
Financial Efficiency
Return on equity (ROE) is 2.99% and return on invested capital (ROIC) is 4.07%.
| Return on Equity (ROE) | 2.99% |
| Return on Assets (ROA) | 2.61% |
| Return on Invested Capital (ROIC) | 4.07% |
| Return on Capital Employed (ROCE) | 4.81% |
| Weighted Average Cost of Capital (WACC) | 6.51% |
| Revenue Per Employee | 6.11M |
| Profits Per Employee | 122,750 |
| Employee Count | 20 |
| Asset Turnover | 1.17 |
| Inventory Turnover | 3.49 |
Taxes
In the past 12 months, KMS Medisurgi has paid 848,000 in taxes.
| Income Tax | 848,000 |
| Effective Tax Rate | 25.67% |
Stock Price Statistics
The stock price has increased by +6.24% in the last 52 weeks. The beta is 0.40, so KMS Medisurgi's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +6.24% |
| 50-Day Moving Average | 71.90 |
| 200-Day Moving Average | 43.36 |
| Relative Strength Index (RSI) | 81.17 |
| Average Volume (20 Days) | 9,650 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KMS Medisurgi had revenue of INR 122.19 million and earned 2.46 million in profits. Earnings per share was 0.74.
| Revenue | 122.19M |
| Gross Profit | 33.97M |
| Operating Income | 4.37M |
| Pretax Income | 3.30M |
| Net Income | 2.46M |
| EBITDA | 9.08M |
| EBIT | 4.37M |
| Earnings Per Share (EPS) | 0.74 |
Balance Sheet
The company has 11.05 million in cash and 7.73 million in debt, with a net cash position of 3.31 million or 1.00 per share.
| Cash & Cash Equivalents | 11.05M |
| Total Debt | 7.73M |
| Net Cash | 3.31M |
| Net Cash Per Share | 1.00 |
| Equity (Book Value) | 83.15M |
| Book Value Per Share | 24.98 |
| Working Capital | 58.61M |
Cash Flow
In the last 12 months, operating cash flow was 15.13 million and capital expenditures -17.20 million, giving a free cash flow of -2.07 million.
| Operating Cash Flow | 15.13M |
| Capital Expenditures | -17.20M |
| Depreciation & Amortization | 4.71M |
| Net Borrowing | -1.39M |
| Free Cash Flow | -2.07M |
| FCF Per Share | -0.63 |
Margins
Gross margin is 27.80%, with operating and profit margins of 3.57% and 2.01%.
| Gross Margin | 27.80% |
| Operating Margin | 3.57% |
| Pretax Margin | 2.70% |
| Profit Margin | 2.01% |
| EBITDA Margin | 7.43% |
| EBIT Margin | 3.57% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.04%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 0.04% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 6.72% |
| Buyback Yield | -0.53% |
| Shareholder Yield | -0.49% |
| Earnings Yield | 0.56% |
| FCF Yield | -0.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 8 |